|
Influenza
|
0.300 |
Biomarker
|
disease |
CTD_human |
A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.
|
23326326 |
2013 |
|
Spontaneous abortion
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
|
Abortion, Tubal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
|
Early Pregnancy Loss
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
|
Miscarriage
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
|
Malignant neoplasm of prostate
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Expression of PRMT5 and p44 in lung and prostate cancer cells was silenced and their target genes were identified.
|
27480244 |
2016 |
|
Prostate carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Expression of PRMT5 and p44 in lung and prostate cancer cells was silenced and their target genes were identified.
|
27480244 |
2016 |
|
Malignant neoplasm of prostate
|
0.050 |
Biomarker
|
disease |
BEFREE |
Cell proliferation assays with N- and C- terminal deletion mutations indicated that the central portion of p44 is required for nuclear p44 mediated prostate cancer growth inhibition.
|
23734213 |
2013 |
|
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Cell proliferation assays with N- and C- terminal deletion mutations indicated that the central portion of p44 is required for nuclear p44 mediated prostate cancer growth inhibition.
|
23734213 |
2013 |
|
Malignant neoplasm of prostate
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
In contrast to findings in prostate cancer, the expression of p44 shows strong cytoplasmic expression in morphologically normal terminal ductal lobular units, while nuclear p44 is observed in both ductal carcinoma in situ and invasive carcinoma.
|
19840198 |
2010 |
|
Prostate carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
In contrast to findings in prostate cancer, the expression of p44 shows strong cytoplasmic expression in morphologically normal terminal ductal lobular units, while nuclear p44 is observed in both ductal carcinoma in situ and invasive carcinoma.
|
19840198 |
2010 |
|
Malignant neoplasm of prostate
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our results indicate that nuclear p44 and cytoplasmic p44 have distinct and opposing functions in the regulation of prostate cancer cell proliferation.
|
18356297 |
2008 |
|
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our results indicate that nuclear p44 and cytoplasmic p44 have distinct and opposing functions in the regulation of prostate cancer cell proliferation.
|
18356297 |
2008 |
|
Malignant neoplasm of prostate
|
0.050 |
Biomarker
|
disease |
BEFREE |
The forced nuclear localization of p44 inhibited prostate cancer cell growth by G1 cell-cycle arrest.
|
17032745 |
2006 |
|
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
The forced nuclear localization of p44 inhibited prostate cancer cell growth by G1 cell-cycle arrest.
|
17032745 |
2006 |
|
Human anaplasmosis due to Anaplasma phagocytophilum
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Similarly, the p44 genes were differentially expressed in infected C3H mice, in SCID mice, and in cultured HGE bacteria.
|
12183586 |
2002 |
|
Human anaplasmosis due to Anaplasma phagocytophilum
|
0.050 |
Biomarker
|
disease |
BEFREE |
Expression of interleukin-1beta, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44.
|
10816490 |
2000 |
|
Human anaplasmosis due to Anaplasma phagocytophilum
|
0.050 |
Biomarker
|
disease |
BEFREE |
Characterization of p44-homologous genes expressed by the HGE agent in a tissue culture would assist in understanding a role of the p44 multigene family in pathogenesis and immune response in HGE.
|
10364227 |
1999 |
|
Human anaplasmosis due to Anaplasma phagocytophilum
|
0.050 |
Biomarker
|
disease |
BEFREE |
Southern blot results revealed the existence of multigenes homologous to the P44 gene in the genome of the HGE agent.
|
9620397 |
1998 |
|
Human anaplasmosis due to Anaplasma phagocytophilum
|
0.050 |
Biomarker
|
disease |
BEFREE |
, p44 from the agent of human granulocytic ehrlichiosis, msp-2 and msp-4 from Anaplasma marginale, and map-1 from Cowdria ruminantium.
|
9705412 |
1998 |
|
Hepatitis C
|
0.030 |
Biomarker
|
disease |
BEFREE |
Expression of interferon-stimulated genes (ISGs) EI2AK2, ISG15, Mx1 and IFI44 was increased in pDCs from HIV-1-HCV-coinfected individuals and was correlated with fibrosis score (Fibroscan, www.echosens.com, Paris, France and aspartate-aminotransferase/platelet-ratio index score, P = 0.026 and 0.019, respectively).
|
28492391 |
2017 |
|
Hepatitis C
|
0.030 |
Biomarker
|
disease |
BEFREE |
The interferon-alpha (IFN-alpha)-inducible protein IFI44 is associated with hepatitis C virus (HCV) infection, and its function is unknown.
|
17784819 |
2007 |
|
Hepatitis C
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Moreover, the induction of expression at day 28, and pretreatment levels of OAS1 and IFI44 correlated with hepatitis C virus RNA reduction at day 28 (P < 0.05).
|
17302252 |
2006 |
|
Spinal Muscular Atrophy
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Here we present the molecular analysis of SMA candidate genes, the survival motor neuron gene (SMN), the neuronal apoptosis inhibitory protein gene (NAIP) and the p44 gene.
|
10206524 |
1999 |
|
Spinal Muscular Atrophy
|
0.030 |
Biomarker
|
disease |
BEFREE |
Deletion of NAIP and p44 is observed more often in severe SMA, but there is no evidence that these genes play a role in the pathology of the disease.
|
9245983 |
1997 |